The Vanguard Group's Position on Mural Oncology plc Shares

The Vanguard Group, Inc. has disclosed its interests in relation to Mural Oncology plc. As of June 20, 2025, Vanguard holds 773,011 shares, representing a 4.48% stake in the ordinary shares valued at $0.01 each. This disclosure aligns with Rule 8.3 of the Irish Takeover Panel Act of 1997, which mandates transparency for entities with significant interests in relevant securities.

Despite the substantial interest, Vanguard reported limited dealings, with a minor sale of 16 shares at a unit price of USD 2.45. No derivatives or related options have been settled or exercised, indicating a stable position.

No additional agreements or inducements concerning securities have been reported, emphasizing a straightforward disclosure with no hidden arrangements.